Home Capitol Hill ‘Abandoned A Viable Path’: White House Abruptly Pulls FDA Nominee As MAHA...

‘Abandoned A Viable Path’: White House Abruptly Pulls FDA Nominee As MAHA Grassroots Clash With Cassidy

182
0
AI-generated image.

WASHINGTON — Hours before a scheduled Senate committee vote, the White House abruptly pulled Dr. Heidi Overton’s nomination to lead the Food and Drug Administration late Tuesday night — sparking immediate celebrations from Make America Healthy Again activists while drawing a sharp public rebuke from Senate Health Committee Chairman Bill Cassidy, R-La.

Overton, a Johns Hopkins-trained physician and deputy director of the White House Domestic Policy Council, had been scheduled for a Wednesday morning confirmation vote before the Senate Health, Education, Labor, and Pensions (HELP) Committee. With Republicans holding only a razor-thin one-vote majority on the panel — and moderate GOP Sens. Susan Collins of Maine and Lisa Murkowski of Alaska still uncommitted — administration officials concluded she lacked the votes to advance.

Cassidy Blasts White House Over Pro-Life Standoff

The withdrawal triggered an extraordinary public clash with Sen. Cassidy, who had originally criticized Overton’s appointment in August as “almost disqualifying” over her support for breaking up combination childhood vaccines. Having since warmed to Overton — viewing her as a steadying counterbalance to Health and Human Services Secretary Robert F. Kennedy Jr. — Cassidy accused the White House of pulling the plug rather than giving pro-life senators firm assurances on restricting the abortion pill mifepristone.

“Tonight, the White House abandoned a viable confirmation path for Dr. Overton. … My conversations with her convinced me she would follow the science and push back against decisions that put Americans’ health at risk. The last issue was that pro-life Senators sought final assurances from the Administration regarding the Administration’s commitment to life issues. The Administration withdrew Dr. Overton rather than make such commitments.” — Sen. Bill Cassidy (R-La.), Senate HELP Committee Chairman

MAHA Activists Claim Victory As Clock Runs Out

While Cassidy lamented that confirming a permanent FDA chief will now fall to incoming Senate Democrats in January, grassroots leaders aligned with Secretary Kennedy’s MAHA coalition celebrated Overton’s exit as a decisive win against establishment and pharmaceutical industry influence.

Activists had targeted Overton for weeks over concerns she was too accommodating toward Big Pharma and agricultural chemical interests, while former Kennedy aide Calley Means charged that entrenched officials inside the administration had worked “at the behest of industry lobbyists”. Conservative wellness host Alex Clark likewise credited MAHA pressure for derailing a nominee seen as insufficiently committed to Kennedy’s overhaul of chronic disease and food safety regulations.

With the GOP’s Senate majority expiring in weeks, administration officials have begun weighing alternative paths—including tapping outgoing Kansas Sen. Roger Marshall, a conservative physician and OB-GYN who lost his reelection bid earlier this month, or relying on acting leadership to keep Secretary Kennedy’s reform agenda moving forward without handing Senate Democrats a veto.

READ NEXT: The Real Story Behind The 90-Day Blackout Headlines

LEAVE A REPLY

Please enter your comment!
Please enter your name here